Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital

Recruiting Observational Study
Infections With CPB
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This retrospective and prospective study is to investigate the incidence of Carbapenemase-producing bacteria (CPB) at the University Hospital Basel, the time to detection of CPB and to initiation of infection control measures, the risk factors associated with carriage of CPB, type and duration of previously administrated antibiotic medication, antibiotic treatment, as well as to assess the outcome…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with detection of carbapenemase-producing bacteria from January 1st , 2008 until December 31st , 2028 Exclusion Criteria: * Patients with documented refusal of subsequent use of their data
Contacts

Sarah Tschudin Sutter, Prof. Dr. MD

+41 61 328 68 10

sarah.tschudin@usb.ch

CONTACT

Isabelle Vock, Dipl. med

isabelle.vock@usb.ch

CONTACT